A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)

Clinical trial NCT07634471 · RECRUITING

Trial details

NCT number: NCT07634471
Sponsor: Merck Sharp & Dohme LLC
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Follicular Lymphoma

Start date: 2026-06-22
Primary completion: 2032-07-23
Enrollment: 960

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.